Mechanistically, FBXO22 facilitated transcriptional activation of the homologous recombinase Rad51 through upregulation of the transcription factor FOXM1, thus promoting DNA damage repair and lung cancer radioresistance. The gene discussed is FBXO22; the disease is lung carcinoma.